BOOK
Optimal Care for Patients with Epilepsy: Practical Aspects, an Issue of Neurologic Clinics, E-Book
(2016)
Additional Information
Book Details
Abstract
This common and very important disorder of Epilepsy is led by Dr. Steven Schachter in this issue of Neurologic Clinics. The majority of articles review methods for application of standards, guidelines, and consensus statement to clinical practice by Primary Care physicians and general Neurologists using validated and evidence-based tools such as screening instruments and algorithms for a number of critically important topics, ranging from initial evaluation to monitoring patients on treatment to counseling and educating patients on SUDEP and driving. Topics in this issue include: Guidelines and quality standards for adult epilepsy patients; Guidelines and quality standards in care of children with epilepsy; Initial evaluation of the patient with suspected epilepsy; Starting, choosing, changing, and discontinuing treatment; Methods for measuring seizure frequency and severity; Assessment of treatment side effects and quality of life; Screening for depression and anxiety; Counseling patients on driving and employment; Issues for women with epilepsy; Patient education (SUDEP - Sudden Unexpected Death in Epilepsy; Self-management; Adherence; Rescue medication); Optimizing the patient-physician therapeutic alliance.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Optimal Care forPatients with Epilepsy:Practical Aspects | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| EDITOR | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Preface: Practical Approaches to Providing Optimal Care to Patients with Epilepsy\r | vii | ||
| Guidelines and Quality Standards for Adults with Epilepsy\r | vii | ||
| Guidelines and Quality Standards in the Care of Children with Epilepsy\r | vii | ||
| Initial Evaluation of the Patient with Suspected Epilepsy\r | vii | ||
| Screening for Depression and Anxiety in Epilepsy\r | vii | ||
| Starting, Choosing, Changing, and Discontinuing Drug Treatment for Epilepsy Patients\r | viii | ||
| Methods for Measuring Seizure Frequency and Severity\r | viii | ||
| Assessment of Treatment Side Effects and Quality of Life in People with Epilepsy\r | viii | ||
| Issues for Women with Epilepsy\r | ix | ||
| Counseling Epilepsy Patients on Driving and Employment\r | ix | ||
| Patient Education: Identifying Risks and Self-Management Approaches for Adherence and Sudden Unexpected Death in Epilepsy\r | ix | ||
| NEUROLOGIC CLINICS\r\r | x | ||
| FORTHCOMING ISSUES | x | ||
| August 2016 | x | ||
| November 2016 | x | ||
| February 2017 | x | ||
| RECENT ISSUES | x | ||
| February 2016 | x | ||
| November 2015 | x | ||
| August 2015 | x | ||
| Preface Practical Approaches to Providing Optimal Care to Patients with Epilepsy\r | xi | ||
| Guidelines and Quality Standards for Adults with Epilepsy | 313 | ||
| Key points | 313 | ||
| GUIDELINES FOR CLINICAL CARE | 314 | ||
| Clinically Focused Guidelines | 314 | ||
| Comprehensive Guidelines | 315 | ||
| QUALITY INDICATORS AND QUALITY MEASURES | 319 | ||
| HISTORY OF EPILEPSY QUALITY MEASURES | 320 | ||
| AMERICAN ACADEMY OF NEUROLOGY QUALITY MEASURE SETS | 320 | ||
| American Academy of Neurology 2009 Quality Measure Set | 320 | ||
| American Academy of Neurology 2014 Quality Measure Set | 322 | ||
| IMPLEMENTING HIGH-QUALITY CARE IN YOUR PRACTICE | 322 | ||
| REFERENCES | 322 | ||
| Guidelines and Quality Standards in the Care of Children with Epilepsy | 327 | ||
| Key points | 327 | ||
| INTRODUCTION | 327 | ||
| DRIVERS FOR GUIDELINE DEVELOPMENT IN THE UNITED KINGDOM | 327 | ||
| DEFINITIONS OF GUIDELINES | 328 | ||
| COMPONENTS OF A SYSTEMATICALLY DEVELOPED CLINICAL PRACTICE GUIDELINE | 329 | ||
| Scope | 329 | ||
| Stakeholder Involvement | 329 | ||
| Guideline Development | 331 | ||
| Evidence and Recommendations | 331 | ||
| Clarity of Presentation, Applicability, and Editorial Independence | 331 | ||
| WEAKNESSES OF THE EVIDENCE-BASED GUIDELINES APPROACH | 332 | ||
| THE ROLE OF QUALITATIVE LITERATURE: THE LOST TRIBE IN CLINICAL GUIDELINES? | 332 | ||
| GUIDELINE IMPLEMENTATION | 333 | ||
| Dissemination | 334 | ||
| Guideline Appraisal | 334 | ||
| Education and Training | 335 | ||
| Workforce Planning | 335 | ||
| Quality Standards | 335 | ||
| Audit and Benchmarking | 335 | ||
| Clinical Networks | 335 | ||
| SUMMARY | 336 | ||
| REFERENCES | 336 | ||
| Initial Evaluation of the Patient with Suspected Epilepsy | 339 | ||
| Key points | 339 | ||
| INTRODUCTION | 339 | ||
| IS IT EPILEPSY? | 340 | ||
| Definition of Epilepsy | 340 | ||
| When Can We Say Someone Has Epilepsy After a Single Seizure? | 341 | ||
| How Do You Diagnose Epilepsy? | 341 | ||
| How Do We Classify Seizures and Epilepsy Syndromes? | 341 | ||
| ROLE OF INVESTIGATIONS IN PATIENTS WITH SUSPECTED EPILEPSY | 342 | ||
| General Role of Investigations | 342 | ||
| Initial Assessment | 345 | ||
| Determining the Type of Seizure and Epilepsy | 345 | ||
| Guiding Therapy and Prognosis | 346 | ||
| PSYCHOLOGICAL AND COGNITIVE ASSESSMENT | 347 | ||
| Psychological Evaluation | 347 | ||
| Neurocognitive Assessment | 347 | ||
| ROLE OF EARLY REFERRAL TO SPECIALIZED CENTERS | 347 | ||
| SUMMARY | 348 | ||
| REFERENCES | 348 | ||
| Screening for Depression and Anxiety in Epilepsy | 351 | ||
| Key points | 351 | ||
| INTRODUCTION | 351 | ||
| DEFINITION, EPIDEMIOLOGY, AND IMPACT OF DEPRESSION AND ANXIETY IN EPILEPSY | 352 | ||
| MEASURING DEPRESSION AND ANXIETY | 354 | ||
| SCREENING | 354 | ||
| TOOLS TO SCREEN FOR DEPRESSION AND ANXIETY IN EPILEPSY | 355 | ||
| Structured Interviews | 355 | ||
| Composite International Diagnostic Interview | 355 | ||
| Mini-International Neuropsychiatric Interview | 355 | ||
| Semistructured Interviews | 356 | ||
| Structured Clinical Interview for DSM | 356 | ||
| Self-Report | 356 | ||
| Patient Health Questionnaire | 356 | ||
| Neurologic Disorders Depression Inventory for Epilepsy | 357 | ||
| Hospital Anxiety and Depression Scale | 358 | ||
| Generalized Anxiety Disorder-7 | 358 | ||
| SELECTING THE APPROPRIATE TOOL | 358 | ||
| CONSIDERATIONS/KNOWLEDGE GAPS | 359 | ||
| SUMMARY | 359 | ||
| REFERENCES | 360 | ||
| Starting, Choosing, Changing, and Discontinuing Drug Treatment for Epilepsy Patients | 363 | ||
| Key points | 363 | ||
| WHY AND WHEN TO START THE FIRST ANTIEPILEPTIC DRUG? | 364 | ||
| Selecting the First Antiepileptic Drug | 364 | ||
| Treatment Effects of Antiepileptic Drugs in New-Onset Epilepsy | 369 | ||
| Tolerability and safety in new-onset epilepsy | 372 | ||
| Changing Antiepileptic Drugs Because of Poor Efficacy | 372 | ||
| Changing Antiepileptic Drugs Because of Poor Tolerability | 374 | ||
| Therapeutic monitoring | 374 | ||
| The Elderly | 374 | ||
| Stopping Antiepileptic Drug Treatment | 374 | ||
| SUMMARY AND LOOKING AHEAD | 377 | ||
| REFERENCES | 378 | ||
| Methods for Measuring Seizure Frequency and Severity | 383 | ||
| Key points | 383 | ||
| INTRODUCTION | 383 | ||
| SEIZURE SEVERITY SCALES | 384 | ||
| SEIZURE DIARIES | 385 | ||
| SHAKE DETECTORS | 386 | ||
| ELECTRODERMAL RESPONSE | 387 | ||
| ELECTROENCEPHALOGRAM MONITORING | 388 | ||
| REFERENCES | 391 | ||
| Assessment of Treatment Side Effects and Quality of Life in People with Epilepsy | 395 | ||
| Key points | 395 | ||
| INTRODUCTION | 395 | ||
| MAIN DETERMINANTS OF QUALITY OF LIFE IN EPILEPSY | 396 | ||
| Seizures | 396 | ||
| Psychiatric Comorbidities | 396 | ||
| Antiepileptic Drug Effects | 397 | ||
| Cognition | 397 | ||
| Sleep | 397 | ||
| Migraine | 397 | ||
| Social Impairments | 398 | ||
| METHODS OF ASSESSMENT OF QUALITY OF LIFE | 398 | ||
| ASSESSMENT OF MEDICATION EFFECTS | 399 | ||
| STRUCTURED ASSESSMENT OF SIDE EFFECTS | 402 | ||
| SELF-MANAGEMENT STRATEGIES TO IMPROVE QUALITY OF LIFE | 406 | ||
| SUMMARY | 407 | ||
| REFERENCES | 407 | ||
| Issues for Women with Epilepsy | 411 | ||
| Key points | 411 | ||
| INTRODUCTION | 411 | ||
| NEUROSTEROIDS | 411 | ||
| SEX STEROID HORMONE AXIS | 412 | ||
| CATAMENIAL EPILEPSY | 412 | ||
| Menstrual Cycle | 412 | ||
| Criteria for Diagnosis | 413 | ||
| Progesterone Therapy | 413 | ||
| Other Treatments | 414 | ||
| REPRODUCTIVE AND SEXUAL DYSFUNCTION | 414 | ||
| EFFECT OF ANTIEPILEPTIC DRUGS ON REPRODUCTIVE HORMONES | 415 | ||
| EFFECT OF REPRODUCTIVE HORMONES ON ANTIEPILEPTIC DRUGS | 415 | ||
| CONTRACEPTION | 415 | ||
| PREGNANCY | 416 | ||
| Risk of Congenital Malformations with Antiepileptic Drug Use | 416 | ||
| Antiepileptic Drug Monotherapies | 416 | ||
| Polytherapy | 417 | ||
| Cognitive and Behavioral Teratogenesis of Antiepileptic Drugs | 418 | ||
| Other Birth Outcomes | 419 | ||
| Folic Acid Use | 419 | ||
| Antiepileptic Drug Metabolism and Management During Pregnancy | 419 | ||
| BREASTFEEDING | 420 | ||
| MENOPAUSE | 420 | ||
| SUMMARY | 421 | ||
| REFERENCES | 421 | ||
| Counseling Epilepsy Patients on Driving and Employment | 427 | ||
| Key points | 427 | ||
| INTRODUCTION | 427 | ||
| DRIVING | 428 | ||
| Background | 428 | ||
| Driving Standards, Regulations, and Practices | 429 | ||
| Reporting Drivers with Epilepsy | 431 | ||
| Other Driving Issues in Epilepsy | 431 | ||
| COMMERCIAL DRIVING RULES | 433 | ||
| EMPLOYMENT | 433 | ||
| STANDARDS FOR EMPLOYMENT | 435 | ||
| SAFETY AND PREVENTION | 436 | ||
| SELECTED ISSUES IN THE EMPLOYMENT OF PEOPLE WITH EPILEPSY | 437 | ||
| EPILEPSY AND MILITARY SERVICE | 437 | ||
| EPILEPSY AND FEDERAL DISABILITY BENEFITS | 437 | ||
| REFERENCES | 439 | ||
| Patient Education | 443 | ||
| Key points | 443 | ||
| INTRODUCTION | 443 | ||
| GOALS OF PATIENT EDUCATION AND SELF-MANAGEMENT | 444 | ||
| CORE COMPONENTS FOR EPILEPSY EDUCATION | 444 | ||
| OUTCOMES OF EDUCATION AND SELF-MANAGEMENT INTERVENTIONS | 445 | ||
| LEARNING NEEDS AND PRIORITIES | 445 | ||
| Examples of Learning Needs | 445 | ||
| Setting Priorities | 447 | ||
| WHEN SHOULD EDUCATION BE PROVIDED? | 447 | ||
| MEDICATION ADHERENCE | 449 | ||
| Types of Interventions | 449 | ||
| Printed drug information | 449 | ||
| Structured educational programs | 450 | ||
| Self-administered questionnaire | 450 | ||
| Online educational self-management program | 450 | ||
| Seizure diaries and reminders | 451 | ||
| DISCUSSING SUDEP | 451 | ||
| PROVIDER PREFERENCES FOR SUDEP EDUCATION | 452 | ||
| PATIENT AND FAMILY PREFERENCES FOR SUDEP EDUCATION | 453 | ||
| GENERAL PRACTICES FOR SUDEP EDUCATION: THE WHEN, WHAT AND HOW | 453 | ||
| SUMMARY | 454 | ||
| REFERENCES | 454 | ||
| Index | 457 |